Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
EV/EBIT

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 13.6810.5810.926.906.65

What is the latest EV/EBIT ratio of AUROBINDO PHARMA ?

The latest EV/EBIT ratio of AUROBINDO PHARMA is 13.68 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar202413.68
Mar202310.58
Mar202210.92
Mar20216.90
Mar20206.65

How is EV/EBIT of AUROBINDO PHARMA Trending?

Years EV/EBIT % Change
Mar2024 13.68
29.30
Mar2023 10.58
-3.11
Mar2022 10.92
58.26
Mar2021 6.9
3.76
Mar2020 6.65 -

Other Financial Ratios of AUROBINDO PHARMA


Compare EV/EBIT ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹67,294.4 Cr 0.1% 9.5% 4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,306.0 Cr -2.5% 7.6% 4.7% Stock Analytics
DIVIS LABORATORIES ₹150,343.0 Cr -3% 3.4% 61.5% Stock Analytics
CIPLA ₹117,323.0 Cr -1.6% 3% -3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,619.0 Cr -0.3% 9% 22.3% Stock Analytics
DR REDDYS LABORATORIES ₹95,941.5 Cr -1.2% 2.9% -6.4% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

0.1%

9.5%

4.2%

SENSEX

-1.8%

2.7%

5%


You may also like the below Video Courses